Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

actinium Ac 225-DOTA-MTI-201

A radioconjugate composed of a melanocyte-stimulating hormone receptor (MSHR; melanocortin-1 receptor; MC1R; melanin-activating peptide receptor; melanotropin receptor)-targeting ligand conjugated to the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA), and labeled with the alpha-emitting radioisotope actinium Ac 225, with potential antineoplastic activity. Upon administration of actinium Ac 225-DOTA-MTI-201, MT-201 targets and binds to MC1R-expressing melanoma cells, thereby specifically delivering a cytotoxic dose of alpha radiation to cells expressing MC1R. MC1R, a G protein-coupled receptor expressed by melanocytes that binds to melanocortins, is involved in regulating mammalian skin and hair color. It is upregulated on the surface of on uveal and cutaneous melanoma cells, but not in healthy normal tissues.
Synonym:225Ac-DOTA-MTI-201
225Ac-MTI-201
actinium Ac 225 MTI 201
actinium Ac 225 MTI-201
actinium Ac 225 MTI201
actinium-225 Labeled MTI-201
Search NCI's Drug Dictionary